Executive Shuffle Reshapes Medtech Leadership Landscape in 2025

Industry Giants See Significant C-Suite Changes
The medical technology sector has witnessed a wave of high-profile executive transitions in 2025, signaling a shift in leadership across several major companies. These changes are likely to have far-reaching implications for the industry's strategic direction and competitive landscape.
Departures and Appointments at Key Players
At Intuitive Surgical, a pioneer in robotic-assisted surgery, CEO Gary Guthart stepped down in July after a 15-year tenure at the helm. This move marks the end of an era for the company, which has dominated the surgical robotics market under Guthart's leadership.
Similarly, Dexcom, a leader in continuous glucose monitoring systems, announced in January that CEO Kevin Sayer would be departing after a decade in the role. Sayer's exit comes at a critical juncture for Dexcom as it faces increasing competition in the diabetes technology space.
In a notable appointment, Ashley McEvoy, formerly of Johnson & Johnson MedTech, took the reins as CEO of Insulet in April. Insulet, known for its innovative insulin pump technology, has been experiencing rapid growth, and McEvoy's leadership is expected to further accelerate the company's expansion.
Reshuffling in Specialized Sectors
The cardiovascular segment also saw significant changes, with Edwards Lifesciences losing Larry Wood, the long-standing leader of its transcatheter aortic valve replacement (TAVR) business. Wood's departure could potentially impact the company's position in the highly competitive TAVR market.
Impact on Industry Dynamics
These executive changes come at a time of intense innovation and competition in the medtech industry. As new leaders take the helm at major firms, industry observers anticipate shifts in corporate strategies, research and development priorities, and potentially, merger and acquisition activities.
The influx of new leadership talent, particularly executives with diverse industry backgrounds like Ashley McEvoy, may bring fresh perspectives to longstanding industry challenges and opportunities. This could lead to new collaborations, technological advancements, and business models in the coming years.
References
- Medtech firms shuffle execs in 2025
Top roles at Intuitive, Boston Scientific, Dexcom and others changed hands this year. Read MedTech Dive’s roundup for all the details.
Explore Further
What strategic shifts are expected in the medtech industry due to the leadership changes at Intuitive Surgical and Dexcom?
How might Ashley McEvoy's background influence Insulet's expansion and innovation in the insulin pump market?
What impact could Larry Wood's departure have on Edwards Lifesciences' competitive position in the TAVR market?
How have executive transitions historically affected research and development priorities in the medtech industry?
What are the potential reasons behind the recent wave of executive changes in major medtech companies?